Is the Benefit of Treating Iron Deficiency Greater in Acute Heart Failure with Renal Dysfunction?
Raquel López-VilellaBorja Guerrero CerveraVíctor Donoso TrenadoIgnacio Sánchez-LázaroLuis Martínez DolzLuis Almenar-BonetPublished in: Life (Basel, Switzerland) (2023)
The administration of FCM in patients with AHF and ID reduces the combined event analysed. The benefit is greater when renal dysfunction is present, except in very advanced degrees where no significant benefit is obtained.